Dimensional Fund Advisors LP Guardant Health, Inc. Transaction History

Dimensional Fund Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$25.44 - $59.78 $53,347 - $125,358	2,097 Added 4.75%	46,236 $1.26 Million
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $1.3 Million - $1.82 Million	-29,874 Reduced 40.36%	44,139 $2.38 Million
Q2 2022 Aug 12, 2022	SELL	$28.82 - $77.35 $3.35 Million - $8.99 Million	-116,288 Reduced 61.11%	74,013 $2.99 Million
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $1.24 Million - $2.58 Million	-25,673 Reduced 11.89%	190,301 $12.6 Million
Q4 2021 Feb 09, 2022	BUY	$88.71 - $120.43 $824,293 - $1.12 Million	9,292 Added 4.5%	215,974 $21.6 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $560,223 - $749,668	5,672 Added 2.82%	206,682 $25.8 Million
Q2 2021 Aug 12, 2021	SELL	$109.77 - $165.68 $88,803 - $134,035	-809 Reduced 0.4%	201,010 $25 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $561,516 - $791,622	4,420 Added 2.24%	201,819 $30.8 Million
Q4 2020 Feb 25, 2021	BUY	$99.96 - $135.93 $19.7 Million - $26.8 Million	197,399 New	197,399 $25.4 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.82B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.